Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Defects in trafficking bridge Parkinson's disease pathology and genetics
Asa Abeliovich, Aaron D. Gitler
Nature (2016) Vol. 539, Iss. 7628, pp. 207-216
Closed Access | Times Cited: 425

Showing 1-25 of 425 citing articles:

Hallmarks of neurodegenerative diseases
David M. Wilson, Mark Cookson, Ludo Van Den Bosch, et al.
Cell (2023) Vol. 186, Iss. 4, pp. 693-714
Open Access | Times Cited: 790
Neurodegenerative disease: models, mechanisms, and a new hope
Aaron D. Gitler, Paraminder Dhillon, James Shorter
Disease Models & Mechanisms (2017) Vol. 10, Iss. 5, pp. 499-502
Open Access | Times Cited: 665
VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites
Nikit Kumar, Marianna Leonzino, William Hancock‐Cerutti, et al.
The Journal of Cell Biology (2018) Vol. 217, Iss. 10, pp. 3625-3639
Open Access | Times Cited: 510
Converging pathways in neurodegeneration, from genetics to mechanisms
Li Gan, Mark Cookson, Leonard Petrucelli, et al.
Nature Neuroscience (2018) Vol. 21, Iss. 10, pp. 1300-1309
Open Access | Times Cited: 414
Determinants of dopaminergic neuron loss in Parkinson's disease
D. James Surmeier
FEBS Journal (2018) Vol. 285, Iss. 19, pp. 3657-3668
Open Access | Times Cited: 338
Autophagy in neurodegenerative diseases: pathogenesis and therapy
Fang Guo, Xinyao Liu, Huaibin Cai, et al.
Brain Pathology (2017) Vol. 28, Iss. 1, pp. 3-13
Open Access | Times Cited: 333
Precisely measured protein lifetimes in the mouse brain reveal differences across tissues and subcellular fractions
Eugenio F. Fornasiero, Sunit Mandad, Hanna Wildhagen, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 303
Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease
Angelique di Domenico, Giulia Carola, Carles Calatayud, et al.
Stem Cell Reports (2019) Vol. 12, Iss. 2, pp. 213-229
Open Access | Times Cited: 303
Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
Jéssika Cristina Bridi, Frank Hirth
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 302
Role of cholesterol and sphingolipids in brain development and neurological diseases
Ghulam Hussain, Jing Wang, Azhar Rasul, et al.
Lipids in Health and Disease (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 289
Autophagy and Microglia: Novel Partners in Neurodegeneration and Aging
Ainhoa Plaza‐Zabala, Virginia Sierra‐Torre, Amanda Sierra
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 3, pp. 598-598
Open Access | Times Cited: 283
Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein
Wenyan Zou, Tinglin Pu, Weixi Feng, et al.
Translational Neurodegeneration (2019) Vol. 8, Iss. 1
Open Access | Times Cited: 267
The physiological role of α‐synuclein and its relationship to Parkinson’s Disease
David Sulzer, Robert H. Edwards
Journal of Neurochemistry (2019) Vol. 150, Iss. 5, pp. 475-486
Open Access | Times Cited: 254
GBA, Gaucher Disease, and Parkinson’s Disease: From Genetic to Clinic to New Therapeutic Approaches
Giulietta Riboldi, Alessio Di Fonzo
Cells (2019) Vol. 8, Iss. 4, pp. 364-364
Open Access | Times Cited: 244
Mitochondria-lysosome contacts regulate mitochondrial Ca 2+ dynamics via lysosomal TRPML1
Wesley Peng, Yvette C. Wong, Dimitri Krainc
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 32, pp. 19266-19275
Open Access | Times Cited: 232
Mitochondria–Lysosome Crosstalk: From Physiology to Neurodegeneration
Cláudia M. Deus, King Faisal Yambire, Paulo J. Oliveira, et al.
Trends in Molecular Medicine (2019) Vol. 26, Iss. 1, pp. 71-88
Open Access | Times Cited: 226
Dopamine, Oxidative Stress and Protein–Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases
Enrico Monzani, Stefania Nicolis, Simone Dell’Acqua, et al.
Angewandte Chemie International Edition (2018) Vol. 58, Iss. 20, pp. 6512-6527
Closed Access | Times Cited: 217
Structure of LRRK2 in Parkinson’s disease and model for microtubule interaction
Colin K. Deniston, John Salogiannis, Sebastian Mathea, et al.
Nature (2020) Vol. 588, Iss. 7837, pp. 344-349
Open Access | Times Cited: 201
Neuronal lysosomal dysfunction releases exosomes harboring APP C-terminal fragments and unique lipid signatures
André Miguel Miranda, Zofia M. Lasiecka, Yimeng Xu, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 198
Genetic risk factors in Parkinson’s disease
Kimberley Billingsley, Sara Bandrés‐Ciga, Sara Sáez-Atiénzar, et al.
Cell and Tissue Research (2018) Vol. 373, Iss. 1, pp. 9-20
Open Access | Times Cited: 198
Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson’s Disease Models
Angelo Iannielli, Simone Bido, Lucrezia Folladori, et al.
Cell Reports (2018) Vol. 22, Iss. 8, pp. 2066-2079
Open Access | Times Cited: 192
Parkinson’s disease: proteinopathy or lipidopathy?
Saranna Fanning, Dennis J. Selkoe, Ulf Dettmer
npj Parkinson s Disease (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 184
Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders
Junchao Tong, Gausiha Rathitharan, Jeffrey H. Meyer, et al.
Brain (2017) Vol. 140, Iss. 9, pp. 2460-2474
Open Access | Times Cited: 176
The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis
Ting Shen, Yumei Yue, Tingting He, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 171
Prussian Blue Nanozyme as a Pyroptosis Inhibitor Alleviates Neurodegeneration
Xinxin Ma, Junnian Hao, Jianrong Wu, et al.
Advanced Materials (2022) Vol. 34, Iss. 15
Closed Access | Times Cited: 166
Page 1 - Next Page

Scroll to top